ACADIA Pharmaceuticals Inc (ACAD): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 30,526 US Dollar | 10 | 4 | 5 | 0 | 1 |
| #Shares | Short [%] | Short Ratio |
| 172.305.518 | 8,34 | 3,81 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name ACADIA Pharmaceuticals Inc
Mitarbeiter 796
Handelsplatz NASDAQ
Ticker Symbol ACAD
IPO Datum 2004-05-27
Adresse 12830 El Camino Real, San Diego, CA, United States, 92130
Webseite https://acadia.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Ms. Catherine E. Owen Adams | CEO & Director |
| 2 | Mr. Mark C. Schneyer | Executive VP & CFO |
| 3 | Ms. Jennifer J. Rhodes J.D. | Executive VP, Chief Legal Officer & Secretary |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Baker Bros Advisors LP | 24,91% | 0,87 Mrd. USD |
| 2 | BlackRock Inc | 13,07% | 0,46 Mrd. USD |
| 3 | State Street Corp | 5,27% | 0,18 Mrd. USD |
| 4 | Vanguard Portfolio Management, LLC | 5,13% | 0,18 Mrd. USD |
| 5 | RTW INVESTMENTS, LLC | 4,15% | 0,15 Mrd. USD |
| 6 | Vanguard Capital Management, LLC | 3,35% | 0,12 Mrd. USD |
| 7 | Dimensional Fund Advisors, Inc. | 2,14% | 0,08 Mrd. USD |
| 8 | Geode Capital Management, LLC | 1,95% | 0,07 Mrd. USD |
| 9 | Palo Alto Investors, LLC | 1,66% | 0,06 Mrd. USD |
| 10 | The Goldman Sachs Group Inc | 1,50% | 0,05 Mrd. USD |
| 11 | Qube Research & Technologies | 1,42% | 0,05 Mrd. USD |
| 12 | Point72 Asset Management, L.P. | 1,41% | 0,05 Mrd. USD |
| 13 | Citadel Advisors Llc | 1,27% | 0,04 Mrd. USD |
| 14 | Pictet Asset Manangement SA | 1,15% | 0,04 Mrd. USD |
| 15 | Arrowstreet Capital Limited Partnership | 1,14% | 0,04 Mrd. USD |
| 16 | Marshall Wace Asset Management Ltd | 1,02% | 0,04 Mrd. USD |
| 17 | D. E. Shaw & Co LP | 0,99% | 0,04 Mrd. USD |
| 18 | BRAIDWELL LP | 0,96% | 0,03 Mrd. USD |
| 19 | NORGES BANK | 0,94% | 0,03 Mrd. USD |
| 20 | Frazier Life Sciences Management, L.P. | 0,83% | 0,03 Mrd. USD |